Skip to content

Evaluation and testing of the microvascular function in asymptomatic athletes

Evaluation and testing of the microvascular function in asymptomatic athletes - ESTIMATE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44625
Enrollment
22
Registered
2017-06-27
Start date
2017-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microvasculair function the function of the smaller cardiac blood vessels

Interventions

Sponsors

Cardiologie
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Index group: asymptomatic athletes with concordant abnormal exercise electrocardiography results and abnormal myocardial perfusion scintigraphy results but without the presence of epicardial coronary artery disease. ;An athlete is defined as a sportsmen who is engaged in sports for at least 2.5 hours a week for a period of minimally 30 weeks per year or in two or more sports with a minimum of 1.5 hours per week within one type of sports for at least 20 weeks per year;Control group: Individuals with a low a priori risk of CAD and without presence of significant epicardial coronary artery disease who last year already have undergone PET/CT as part of a prior diagnostic procedure.

Exclusion criteria

Exclusion criteria: Symptomatic athletes ((Exercise induced) chest pain, palpitations, dizziness, light headiness or syncope), athletes with epicardial coronary artery disease, athletes with previous myocardial infarction

Design outcomes

Primary

MeasureTime frame
* Myocardial blood flow (MBF) per gram of myocardial tissue (ml/min/g) with 82Rb PET-CT imaging. * Myocardial flow reserve (MBF at peak hyperaemia / MBF at rest) with 82Rb PET-CT imaging.

Secondary

MeasureTime frame
* The plasma levels of eNOS and ET-1 in athletes with a normal and abnormal exercise test result.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)